It was reported that on (b)(6) 2014, a 2.75 x 18 mm xience xpedition stent was implanted in the narrow, 80% stenosed, mid, left anterior descending (lad) coronary artery and the patient was discharged on (b)(6) 2014.Information received at the yearly follow-up visits indicates that on (b)(6) 2014, (b)(6) 2015, (b)(6) 2016, (b)(6) 2017 the patient experienced one or more of the following; intermittent anterior cardiac discomfort, chest pain, chest tightness, insomnia, palpitations, light-headedness, weakness, and was admitted each time to the hospital where medical treatment was given and was subsequently discharged a few days later without further intervention.Per the physician, the correlation between events and device is not known.No additional information was provided.
|
(b)(4).The device was not returned for evaluation.A review of the lot history record of the reported device could not be conducted because the lot number was not provided.The reported patient effects of angina and arrhythmia are listed in the xience xpeditiion, everolimus eluting coronary stent systems instructions for use as known patient effects of coronary stenting procedures.A conclusive cause for the reported patient effects, and the relationship to the product, if any, cannot be determined.There is no indication of a product quality issue with respect to manufacture, design or labeling.
|